As of December 3 at 10:06 AM GMT+11. Market Open.

The research paper titled "Recruiting the Immune System against Pathogenic Bacteria Using High-Affinity Chimeric Tags" is published in the journal Bioconjugate Chemistry. Pathogens often escape ...

Chimeric Therapeutics Ltd. (AU:CHM) has released an update. Chimeric Therapeutics Ltd. has amended its company constitution, highlighting key changes in share capital and shareholder rights. These ...

The pharmaceutical company also has platforms for the discovery of B cell therapies, chimeric antigen receptor T cell therapies, and chicken antibody therapies. The US Food and Drug Administration ...

Despite challenges such as high attrition rates and adverse events, the trial highlights the value of established therapies ...

One-third of HER2-positive (HER2+) tumors express the P95HER2 protein, which associates with an aggressive form of breast ...

Infliximab is a chimeric monoclonal antibody against tumour-necrosis factor-α (TNF-α), which has demonstrated efficacy in patients who do not respond to traditional therapies 2,4. Since then ...

The FDA continues to approve new drugs and expand indications for others at a rapid pace. Here’s a summary of what happened ...

No writing assistance was utilized in the production of this manuscript. Monoclonal antibodies are novel therapeutic agents used with great success in the treatment of rheumatoid arthritis (RA).

1Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York. 9Early Drug Development Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York ...

Matias Sanchez, MD, assistant professor in the Department of Medicine at the University of Illinois Chicago, discussed recent advancements in multiple myeloma treatment, including the potential of ...